151 related articles for article (PubMed ID: 7020931)
1. Relationship of steroid receptor, cell kinetics, and clinical status in patients with breast cancer.
Kute TE; Muss HB; Anderson D; Crumb K; Miller B; Burns D; Dube LA
Cancer Res; 1981 Sep; 41(9 Pt 1):3524-9. PubMed ID: 7020931
[TBL] [Abstract][Full Text] [Related]
2. Prognostic indicators including DNA histogram type, receptor content, and staging related to human breast cancer patient survival.
Coulson PB; Thornthwaite JT; Woolley TW; Sugarbaker EV; Seckinger D
Cancer Res; 1984 Sep; 44(9):4187-96. PubMed ID: 6744328
[TBL] [Abstract][Full Text] [Related]
3. [Study of DNA content using a flow cytometry method and steroid hormone receptors in breast cancer].
Zubrikhina GN; Kuz'mina EV; Bassalyk LS; Murav'eva NI
Vopr Onkol; 1989; 35(10):1179-86. PubMed ID: 2596061
[TBL] [Abstract][Full Text] [Related]
4. [Assay of DNA content and estrogen receptor status in human breast cancer].
Chen GJ; Shao YF; Shan Y
Zhonghua Zhong Liu Za Zhi; 1994 Nov; 16(6):461-4. PubMed ID: 7720507
[TBL] [Abstract][Full Text] [Related]
5. Determination of threshold values for determining the size of the fraction of steroid hormone receptor-positive tumor cells in paraffin-embedded breast carcinomas.
Leers MP; Hoop JG; van Beers M; van Rodijnen N; Pannebakker M; Nap M
Cytometry B Clin Cytom; 2005 Mar; 64(1):43-52. PubMed ID: 15668953
[TBL] [Abstract][Full Text] [Related]
6. Ploidy, proliferative activity and estrogen receptor content in human breast cancer.
Raber MN; Barlogie B; Latreille J; Bedrossian C; Fritsche H; Blumenschein G
Cytometry; 1982 Jul; 3(1):36-41. PubMed ID: 7117052
[TBL] [Abstract][Full Text] [Related]
7. Mutant p53 expression and DNA analysis in human breast cancer comparison with conventional clinicopathological parameters.
Rosanelli GP; Steindorfer P; Wirnsberger GH; Klimpfinger M; Ratschek M; Puerstner P; Auner H; Berhold A
Anticancer Res; 1995; 15(2):581-6. PubMed ID: 7763041
[TBL] [Abstract][Full Text] [Related]
8. Comparison of proliferation activity in breast carcinoma by flow cytometry analysis of S-phase and quantitative analysis of MIB-1.
Masood S; Bui MM; Lu L
Ann Clin Lab Sci; 1998; 28(6):315-23. PubMed ID: 9846198
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of a modeling system for S-phase estimation in breast cancer by flow cytometry.
Dressler LG; Seamer L; Owens MA; Clark GM; McGuire WL
Cancer Res; 1987 Oct; 47(20):5294-302. PubMed ID: 3652035
[TBL] [Abstract][Full Text] [Related]
10. [Expression of steroid receptors and DNA synthesis in male breast cancer].
Petroni S; Mangia A; D'Amico C; Simone G
Pathologica; 2003 Feb; 95(1):31-6. PubMed ID: 12735283
[TBL] [Abstract][Full Text] [Related]
11. [Breast cancer: prognostic value of flow cytometry and hormone receptors. Apropos of a Lebanese series of patients].
Aftimos G; Trak-Smayra V; Moacdieh-Rehayel L
J Med Liban; 2000; 48(1):8-17. PubMed ID: 10881437
[TBL] [Abstract][Full Text] [Related]
12. [Content of 17 beta éstradiol, progesterone and glucocorticoid receptors in patients with benign breast diseases].
Bassalyk LS; Kuz'mina ZV; Murav'eva NI; Smirnova KD; Vishniakova VV
Vopr Onkol; 1982; 28(7):3-6. PubMed ID: 7101825
[TBL] [Abstract][Full Text] [Related]
13. The S-phase fraction of the aneuploid cell subpopulation is the biologically relevant one in aneuploid breast cancers.
Martinez-Arribas F; Nuñez-Villar MJ; Lucas AR; Sanchez J; Tejerina A; Schneider J
Breast Cancer Res Treat; 2005 Jul; 92(1):77-80. PubMed ID: 15980994
[TBL] [Abstract][Full Text] [Related]
14. Differentiated DNA analysis in relation to steroid receptor status, grading, and staging in human breast cancer.
Meckenstock G; Bojar H; Hort W
Anticancer Res; 1987; 7(4B):749-54. PubMed ID: 3674762
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy is more effective in patients with breast cancer not expressing steroid hormone receptors: a study of preoperative treatment.
Colleoni M; Viale G; Zahrieh D; Pruneri G; Gentilini O; Veronesi P; Gelber RD; Curigliano G; Torrisi R; Luini A; Intra M; Galimberti V; Renne G; Nolè F; Peruzzotti G; Goldhirsch A
Clin Cancer Res; 2004 Oct; 10(19):6622-8. PubMed ID: 15475452
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of prostate-specific antigen for women with breast cancer: a large United States cohort study.
Yu H; Levesque MA; Clark GM; Diamandis EP
Clin Cancer Res; 1998 Jun; 4(6):1489-97. PubMed ID: 9626467
[TBL] [Abstract][Full Text] [Related]
17. Relationship of flow cytometry results to clinical and steroid receptor status in human breast cancer.
Kute TE; Muss HB; Hopkins M; Marshall R; Case D; Kammire L
Breast Cancer Res Treat; 1985; 6(2):113-21. PubMed ID: 4052638
[TBL] [Abstract][Full Text] [Related]
18. Downregulation of the potential suppressor gene IGFBP-rP1 in human breast cancer is associated with inactivation of the retinoblastoma protein, cyclin E overexpression and increased proliferation in estrogen receptor negative tumors.
Landberg G; Ostlund H; Nielsen NH; Roos G; Emdin S; Burger AM; Seth A
Oncogene; 2001 Jun; 20(27):3497-505. PubMed ID: 11429696
[TBL] [Abstract][Full Text] [Related]
19. Determination of ploidy and steroid receptor status in breast cancer by laser scanning cytometry.
Bollmann R; Torka R; Schmitz J; Bollmann M; Méhes G
Cytometry; 2002 Aug; 50(4):210-5. PubMed ID: 12210600
[TBL] [Abstract][Full Text] [Related]
20. DNA flow cytometry and prognostic factors in 1331 frozen breast cancer specimens.
Dressler LG; Seamer LC; Owens MA; Clark GM; McGuire WL
Cancer; 1988 Feb; 61(3):420-7. PubMed ID: 3338012
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
